Our experimental results demonstrate that upregulating a chRCC-specific TF, FOXI1, can partially reprogram a ccRCC cell line, 786-O, towards a chRCC transcriptional phenotype; consistent with results from other tumor and normal cell types showing that master TFs govern the transcriptional identity of the cell or tissue. This evidence concerns the gene TF and chromophobe renal cell carcinoma.